Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents

Cancer Research

Volumn 66, Issue 20, 2006, Pages 9921-9928

  Hyodo, Fuminori ^a   Matsumoto, Ken Ichiro ^a   Matsumoto, Atsuko ^a   Mitchell, James B ^a   Krishna, Murali C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CARBAMOYL 2,2,5,5 TETRAMETHYLPYRROLIDINE 1 OXYL; 3 CARBOXY 2,2,5,5 TETRAMETHYLPYRROLIDINE 1 OXYL; CONTRAST MEDIUM; NITROXIDE DERIVATIVE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; FEMUR SHAFT; LIPOPHILICITY; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RADIOISOTOPE DECAY; TUMOR;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; CYCLIC N-OXIDES; FEMALE; FREE RADICALS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; NITROGEN OXIDES; OXIDATION-REDUCTION; PYRROLIDINES; SPIN LABELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750553403     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0879     Document Type: Article

References (45)

1. Ronen SM, Leach MO. Imaging biochemistry: applications to breast cancer. Breast Cancer Res 2001;3:36-40.
2. Bhujwalla ZM, Artemov D, Aboagye E, et al. The physiological environment in cancer vascularization, invasion and metastasis [discussion 45, 152-3]. Novartis Found Symp 2001;240:23-38.
3. Bolan PJ, Nelson MT, Yee D, Garwood M. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res 2005;7:149-52.
4. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002;16:451-63.
5. Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of chorine compounds in the breast with IH MR spectroscopy. Magn Reson Med 2003;50:1134-43.
6. Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ. Identification of MRI and IH MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004;17:10-20.
7. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-212.
8. Kuppusamy P, Afeworki M, Shankar RA, et al. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res 1998;58:1562-8.
9. Kuppusamy P, Li H, Ilangovan G, et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 2002;62:307-12.
10. Beauregard DA, Hill SA, Chaplin DJ, Brindle KM. The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability. Cancer Res 2001;61:6811-5.
11. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-16.
12. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004;4:437-47.
13. Benard F, Turcotte E. Imaging in breast cancer: single-photon computed tomography and positron-emission tomography. Breast Cancer Res 2005;7:153-62.
14. Verreault J, Turcotte E, Benard F, Mongeau CJ, Boileau R. Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung. Clin Nucl Med 2001;26:79-80.
15. Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002;15:154-63.
16. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16:407-22.
17. Padhani AR, Leach MO. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging 2005;30:324-41.
18. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003;17:509-20.
19. Brasch RC, London DA, Wesbey GE, et al. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 1983;147:773-9.
20. Brasch RC, Nitecki DE, Brant-Zawadzki M, et al. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. AJR Am J Roentgenol 1983;141:1019-23.
21. Hahn SM, Wilson L, Krishna CM, et al. Identification of nitroxide radioprotectors. Radiat Res 1992;132:87-93.
22. Samuni AM, DeGraff W, Krishna MC, Mitchell JB. Cellular sites of H2O2-induced damage and their protection by nitroxides. Biochim Biophys Acta 2001;1525:70-6.
23. Koretsky AP, Silva AC. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 2004;17:527-31.
24. Keana JF, Pou S. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents. Physiol Chem Phys Med NMR 1985;17:235-40.
25. Matsumoto K, Hyodo F, Matsumoto A, et al. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res 2006;12:2455-62.
26. Mitchell JB, Russo A, Kuppusamy P, Krishna MC. Radiation, radicals, and images. Ann N Y Acad Sci 2000;899:28-43.
27. Krishna MC, Grahame DA, Samuni A, Mitchell JB, Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A 1992;89:5537-41.
28. 2 or as SOD mimics? J Biol Chem 1996;271:26026-31.
29. Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem 1996;271:26018-25.
30. Goldstein S, Samuni A, Hideg K, Merenyi G. Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. J Phys Chem A Mol Spectrosc Kinet Environ Gen Theory 2006;110:3679-85.
31. Dikalov S, Grigor'ev IA, Voinov M, Bassenge E. Detection of superoxide radicals and peroxynitrite by 1-hydroxy-4-phosphonooxy-2,2,6,6- tetramethyipiperidine: quantification of extracellular superoxide radicals formation. Biochem Biophys Res Commun 1998;248:211-5.
32. Chen K, Glockner JF, Morse PD II, Swartz HM. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry 1989;28:2496-501.
33. Samuni Y, Gamson J, Samuni A, et al. Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid Redox Signal 2004;6:587-95.
34. Kuppusamy P, Chzhan M, Wang P, Zweier JL. Three-dimensional gated EPR imaging of the beating heart: time-resolved measurements of free radical distribution during the cardiac contractile cycle. Magn Reson Med 1996;35:323-8.
35. Hahn SM, Krishna MC, DeLuca AM, Coffin D, Mitchell JB. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic Biol Med 2000;28:953-8.
36. Krishna MC, DeGraff W, Hankovszky OH, et al. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J Med Chem 1998;41:3477-92.
37. Hahn SM, Krishna CM, Samuni A, et al. Potential use of nitroxides in radiation oncology. Cancer Res 1994;54:2006-10s.
38. Koscielniak J, Devasahayam N, Moni MS, et al. 300 MHz continuous wave electron paramagnetic resonance spectrometer for small animal in vivo imaging. Rev Sci Instrum 2000;71:4273-81.
39. Chen K, Morse PD II, Swartz HM. Kinetics of enzyme-mediated reduction of lipid soluble nitroxide spin labels by living cells. Biochim Biophys Acta 1988;943:477-84.
40. Prescott DM, Charles HC, Poulson JM, et al. The relationship between intracellular and extracellular pH in spontaneous canine tumors. Clin Cancer Res 2000;6:2501-5.
41. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 2000;6:157-62.
42. Kurhanewicz J, Vigneron DB, Hricak H, et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 1996;200:489-96.
43. Swartz HM, Chen K, Pals M, Sentjurc M, Morse PD, II. Hypoxia-sensitive NMR contrast agents. Magn Reson Med 1986;3:169-74.
44. Swartz HM, Sentjurc M, Morse PD II. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim Biophys Acta 1986;888:82-90.
45. Yamada KI, Kuppusamy P, English S. et al. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol 2002;43:433-40.